Hinge Health, Inc. Amortization of Deferred Sales Commissions
Hinge Health, Inc. (HNGE) reported Amortization of Deferred Sales Commissions of $35.29 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:AmortizationOfDeferredSalesCommissions · last filed 2026-08-06
- Hinge Health, Inc. amortization of deferred sales commissions for the quarter ending 2026-06-30 was $19.09M, a 78.70% increase year-over-year.
- Hinge Health, Inc. amortization of deferred sales commissions for the quarter ending 2026-03-31 was $16.20M, a 76.33% increase year-over-year.
- Hinge Health, Inc. amortization of deferred sales commissions for the quarter ending 2025-12-31 was $14.23M, a 57.56% increase year-over-year.
- Hinge Health, Inc. amortization of deferred sales commissions for the quarter ending 2025-09-30 was $12.57M, a 68.20% increase year-over-year.
- Hinge Health, Inc. amortization of deferred sales commissions for fiscal 2025 was $46.67M, a 56.00% increase from fiscal 2024.
- Hinge Health, Inc. amortization of deferred sales commissions for fiscal 2024 was $29.91M, a 47.08% increase from fiscal 2023.
- Hinge Health, Inc. amortization of deferred sales commissions for fiscal 2023 was $20.34M.
| Period end | Amortization of Deferred Sales Commissions 3 month | Amortization of Deferred Sales Commissions 6 month | Amortization of Deferred Sales Commissions 9 month | Amortization of Deferred Sales Commissions 12 month |
|---|---|---|---|---|
| 2026-06-30 | $19.09M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $35.29M 10-Q · filed 2026-08-06 | $49.52M derived: sum of 3 quarters · filed 2026-08-06 | $62.09M derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | $16.20M 10-Q · filed 2026-05-07 | $30.44M derived: sum of 2 quarters · filed 2026-05-07 | $43.00M derived: sum of 3 quarters · filed 2026-05-07 | $53.68M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-12-31 | $14.23M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-03 | $26.80M derived: sum of 2 quarters · filed 2026-03-03 | $37.48M derived: sum of 3 quarters · filed 2026-08-06 | $46.67M 10-K · filed 2026-03-03 |
| 2025-09-30 | $12.57M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-07 | $23.25M derived: sum of 2 quarters · filed 2026-08-06 | $32.44M 10-Q · filed 2025-11-07 | $41.47M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-06-30 | $10.68M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $19.87M 10-Q · filed 2026-08-06 | $28.90M derived: sum of 3 quarters · filed 2026-08-06 | $36.37M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-03-31 | $9.19M 10-Q · filed 2026-05-07 | $18.22M derived: sum of 2 quarters · filed 2026-05-07 | $25.69M derived: sum of 3 quarters · filed 2026-05-07 | |
| 2024-12-31 | $9.03M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-03 | $16.50M derived: sum of 2 quarters · filed 2026-03-03 | $29.91M 10-K · filed 2026-03-03 | |
| 2024-09-30 | $7.47M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-07 | $20.88M 10-Q · filed 2025-11-07 | ||
| 2024-06-30 | $13.41M 10-Q · filed 2025-08-11 | |||
| 2023-12-31 | $20.34M 10-K · filed 2026-03-03 |